
Sacituzumab govitecan combo may be ‘new first-line standard of care’ in breast cancer subset
Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Survival outcomes with the sacituzumab …